![Biofrontera AG logo](/logos/B8F.DE.webp)
Biofrontera AG
FSX:B8F.DE
Overview | Financials
Company Name | Biofrontera AG |
Symbol | B8F.DE |
Currency | EUR |
Price | 6.804 |
Market Cap | 20,673,478 |
Dividend Yield | 0% |
52-week-range | 0.296 - 22.575 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Ms. Pilar de la Huerta Martinez |
Website | https://www.biofrontera.com |
An error occurred while fetching data.
About Biofrontera AG
Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD